Chief Executive Officer & Co-founder
Profile summary: Scuola Superiore Sant'Anna • Postdoctoral Researcher · PhD at Scuola Superiore Sant'Anna

Soundsafe Care develops a medical device that integrates robotics and ultrasound technologies for cancer treatment. This system is designed to perform tumor treatment without requiring incisions or introducing toxicity. The company focuses on advancing surgical standards in oncology care through this innovative technology.
Raised to date
€1.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Est. $1.9Macross 1 round
€1.8M · Seed
Announced Nov 2023
Disclosed cumulative: $1.9M
Chief Executive Officer & Co-founder
Profile summary: Scuola Superiore Sant'Anna • Postdoctoral Researcher · PhD at Scuola Superiore Sant'Anna
Co-founder
Profile summary: TECNALIA Research & Innovation • Visiting Research Scientist · PhD at Scuola Superiore Sant'Anna
Traditional tumor treatments often involve invasive surgical procedures or systemic therapies like chemotherapy, which can lead to significant side effects and prolonged recovery times. These methods may not be suitable for all patients, particularly those with tumors in difficult-to-reach locations or those who are not strong candidates for surgery.
Soundsafe Care is developing a robotic ultrasound system that enables non-invasive tumor treatment, eliminating the need for incisions and reducing toxic side effects. The system uses focused ultrasound waves to precisely target and ablate tumors, offering a safer and more effective alternative to traditional surgical methods. The robotic platform allows for accurate positioning and real-time monitoring of the treatment, ensuring that the ultrasound energy is delivered precisely to the tumor while sparing surrounding healthy tissue. This approach aims to improve patient outcomes, reduce recovery times, and enhance the overall quality of life for individuals undergoing cancer treatment.
The primary target audience includes hospitals, cancer treatment centers, and medical professionals specializing in oncology and surgical robotics.